ABSTRACT. A 5-year-old female Chihuahua was presented for acute collapse. Laboratory examinations showed markedly elevated levels of hepatobiliary enzymes. Empiric antibiotic therapy for bacterial infection of the liver was ineffective. The clinical signs worsened with the development of hyponatremia with hypoosmolality and elevated urine sodium levels. The dog was suspected of having acute cholangiohepatitis associated with an immune-mediated disease. Subsequently, it was diagnosed with syndrome of inappropriate antidiuretic hormone secretion (SIADH) on the basis of the specific disease criteria. Further tests showed normal function of the adrenal and thyroid glands, and MRI and cerebrospinal fluid (CSF) analysis did not show any intracranial diseases. The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a disorder affecting the sodium and water balance in patients and is characterized by hypotonic hyponatremia [4] . SIADH is a rare cause of hyponatremia in animals, and there are few case reports describing the clinical features and diagnosis criteria of SIADH [3, 12] in animals. Hyponatremia with serum hypoosmolality and a high urine sodium concentration are important characteristics of SIADH [13] . Detection of SIADH and determination of the factor stimulating antidiuretic hormone (ADH) secretion may help prevent further deterioration of the condition.
The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a disorder affecting the sodium and water balance in patients and is characterized by hypotonic hyponatremia [4] . SIADH is a rare cause of hyponatremia in animals, and there are few case reports describing the clinical features and diagnosis criteria of SIADH [3, 12] in animals. Hyponatremia with serum hypoosmolality and a high urine sodium concentration are important characteristics of SIADH [13] . Detection of SIADH and determination of the factor stimulating antidiuretic hormone (ADH) secretion may help prevent further deterioration of the condition.
We report a case of SIADH occurring concurrently with suspected immune-mediated liver disease. In this case, immunosuppressive therapy with prednisolone and cyclosporine improved the clinical signs and resolved the SIADH.
A 5-year-old, 2 kg, intact female Chihuahua was presented after an acute collapse. The dog showed a sudden loss of strength. Upon presentation, the dog exhibited hypothermia (34.9°C), delayed capillary refill time and hypotension (93 mmHg; Cardell 9401 BP Monitor, Sharn Veterinary Inc., Tampa, FL, U.S.A.). Venous blood analysis showed mixed acidosis (pH 6.713, reference range, 7.30-7.45; pCO 2 , 81 mmHg, reference range, 33-55 mmHg; HCO 3 , 10.3 mmol/l, reference range, 18-26 mmHg). We started oxygen therapy using face masks, rapid warming, intravenous (IV) catheterization, and treatment with sodium bicarbonate (1 mEq/kg, slowly IV; Huons, Seoul, Korea) and a balanced electrolyte solution (normal saline, 10 ml/kg/hr; JW Life Science, Seoul, Korea). The dog's complete blood count revealed mild thrombocytopenia (184 × 10 3 platelets/µl; reference range, 200-500 × 10 3 platelets/µl). The abnormal serum chemistry findings included elevated levels of several hepatobiliary enzymes, hyperglycemia (285 mg/dl; reference range, 70-118 mg/dl), mild hypoalbuminemia and hyperphosphatemia (11.7 mg/dl, reference range, 3-6.2 mg/dl). Elevated levels of lactate dehydrogenase and creatine kinase (2328 U/K; reference range, 46-320 U/l) were also revealed ( Table 1) . The activated partial thromboplastin time was normal (14.9 sec; reference range, 12-18 sec), while the prothrombin time was higher than normal (over 30 sec; reference range, 6.2-8.2 sec). Ten hours after admission, the results of venous blood gas analysis improved, but the serum levels of hepatobiliary enzymes increased further. The findings on thoracic and abdominal radiographs were unremarkable. Abdominal ultrasonography showed generalized hyperechoic liver parenchyma with a thickened and edematous gallbladder wall (Fig 1A) . We included vitamin K1 (2 mg/kg, SC; Dai Han Pharm, Seoul, Korea), cefazolin (30 mg/kg, IV, Chong Kun Dang, Seoul, Korea), and enrofloxacin (5 mg/kg, SC, Bayer Animal Health Co., Suwon, Korea) in the treatment. The preand postprandial serum levels of bile acid were found to be higher than the normal level (pre-and post prandial bile acid concentrations and reference ranges: 55.8 µmol/l and 0-10 µmol/l and 40.5 µmol/l and 0-25 µmol/l, respectively). Because the dog's acute collapse and elevated liver enzyme activity could be due to hepatic ischemia or hepatic damage caused by toxic products from the pancreas, we also tested for acute pancreatitis. No ultrasonographic changes in the pancreatic region were found, and the serial serum chemistry profiles of amylase and lipase enzyme level were within normal limits. We also checked the serum pancreatic lipase immunoreactivity (cPLI) (<30 µg/l, reference 0-200 µg/l) and trypsin-like immunoreactivity (cTLI) (5.9 µg/l, reference 5-35 µg/l). In order to determine the underlying cause of the disease, we performed ultrasound guided fine-needle aspiration (FNA) biopsy of the liver; we detected degenerative hepatocytes with mild vacuolated cytoplasm and a few necrotic hepatocytes. No causative agents were detected, and bacterial culture tests produced negative results. The patient's serum hepatobiliary enzyme levels showed no improvement after 1 day of treatment, and severe electrolyte imbalance (hyponatremia, 129 mmol/l; hypochloremia, 99 mmol/l; and hypokalemia; 3.5 mmol/l) was also observed. Plasma osmolality (Posm) was 268.98 mOsm/kg (reference range, 290-310 mOsm/kg). Urinalysis showed a specific gravity of 1.012, and urine osmolality (Uosm) was 429 mOsm/kg. The fractional excretion of sodium (FENa) was 1.67% (reference range, 0-0.7%). IV infusion of 0.9% saline with 5 mEq/l potassium chloride (10 ml/hr) was started, and 4 hr later, the serum potassium level was observed to increase; however, hyponatremia could not be corrected. Further diagnostic investigations included the adrenocorticotropic hormone (ACTH) stimulation test using synthetic ACTH (0.125 mg administered intramuscularly; Synacthen, Dalim BioTech, Seoul, Korea). The basal and post-ACTH test serum cortisol concentrations were 5.1 µg/dl (reference range, 1-6 µg/dl) and 11.8 µg/dl (reference range, 5.5-20 µg/dl), respectively, and the serum aldosterone concentrations were 179.3 pmol/l (reference range, 5-344 pmol/l) and 318.4 pmol/l (reference range, 70-757 pmol/l), respectively. The endogenous ACTH level was 37 pg/ml (reference range, 10-110 pg/ml). The total thyroxine concentration was normal (2.8 µg/dl; reference range, 1-4 µg/dl). The clinical and laboratory findings were consistent with those of SIADH. On the basis of the dog's clinical condition, laboratory examination results and poor response to antibiotics, we suspected immune-mediated inflammation, and steroids (prednisolone, 1 mg/kg, BID, PO, Yuhan Pharmaceuticals, Seoul, Korea) were included in the treatment. Water intake was restricted to 70-100 ml per day. The dog's serum was analyzed 2 days after the immunosuppressive treatment, and her hepatobiliary enzyme levels had improved markedly (Table 1) . On day 5 of hospitalization, abdominal ultrasonography was performed again, and the gallbladder wall was observed to be normal (Fig. 1B) . Repeated laboratory examination results showed a steady improvement in the dog's condition (Tables 1 and 2 ). One month after first admission, clinical signs, such as mild shivering and hindlimb weakness, were detected following prednisolone tapering. Thus, the prednisolone dose was lowered gradually, and cyclosporine (5 mg/kg, PO, every 12 hr; Novartis Korea, Seoul, Korea) was added to the treatment regimen. The dog's condition stabilized after immunosuppressive therapy with cyclosporine and water restriction. Four months after the treatment, the dog was clinically healthy, and its water intake had reduced (lower than 100 ml per day). The dog's condition was suspected to be SIADH secondary to liver failure. For a defi- nite diagnosis, exclusion of underlying intracranial disease, which could have caused SIADH, was required. Brain MRI was performed using a 0.2T scanner (E-scan®; ESAOTE, Genova, Italy) to detect structural central nervous system (CNS) diseases. Mild cerebellar atrophy was detected, but no structural abnormalities that could have caused SIADH were detected (Fig. 2) . The results of CSF analysis were normal. The patient underwent follow-up examinations at monthly intervals. No recurrence of the condition was observed (arrowheads) was detected, but no other structural abnormality that could cause SIADH was observed. FENa, fractional excretion of sodium.
during the 8 months of follow-up; most of the serum biochemical abnormalities had been resolved, and the dog was clinically healthy. SIADH can be attributed to euvolemic hyponatremia caused by excessive secretion of ADH without osmotic stimuli, which results in excessive water retention in the body [5, 10] . In humans, SIADH can be caused by various conditions that disrupt the regulation of ADH, including neurologic disorders, neoplasia, nonmalignant lung disease, drugs that effect ADH secretion, and other miscellaneous conditions such as viral infection, postoperative status, and idiopathic conditions [5, 13, 14] . In the veterinary literature, SIADH has been reported only in 6 dogs and 1 cat. The causes of SIADH in these animals included: neurologic disorders (amebic meningoencephalitis, hydrocephalus, and hypothalamic tumors in 3 dogs) [2, 7, 12] , idiopathic etiologies (in 2 dogs) [10] , heartworm disease (in 1 dog) [1] , and laparoscopic procedures (in 1 cat) [3] . SIADH can be definitively diagnosed if the patient's condition fulfills the requisite criteria and other diseases that can cause SIADH are ruled out. The dog had no medical history, and clinical examinations showed a normovolemic status after the acute collapse. Serial laboratory examination results, including bile acid test, ultrasound and FNA biopsy of the liver, indicated the possibility of a liver disease. The results of several laboratory tests indicated normal renal, adrenal, and thyroid functions. Hyponatremia with plasma hyposmolality, inappropriately high Uosm (>100 mOsm/kg) and elevated renal fractional excretion of sodium was observed and was corrected by fluid restriction. These results were consistent with the reported essential and supplemental features of SIADH in humans [4] . According to the reports described previously [12] , structural brain disease should be ruled out before the diagnosis of idiopathic SIADH. The neurons affecting ADH secretion are distributed in the brain. Therefore, a variety of CNS disorders could cause SIADH in humans [4, 11, 13 ], 14 and animals [2, 7, 12] . No structural abnormalities that could have an effect on ADH secretion have been found. However, MRI and CSF analysis have not been performed while the diseases are active, and which makes it impossible to rule out the role of intracranial disease in this case.
Severe liver diseases such as cirrhosis are well known causes of hyponatremia both in humans and animals [3, 6, 13] . In patients with liver cirrhosis, hyponatremia is caused by decreased arterial volume, which triggers arginine vasopressin release and water retention [6] . However, this dog did not show edema or ascites, and her urine sodium concentration and FENa were typically high.
The exact cause of SIADH in this dog could not be determined. We infer that SIADH in this dog may be associated with suspected immune-mediated liver disease. Unfortunately, a liver biopsy could not be performed. The patient's clinical condition and laboratory examination results showed a dramatic improvement after it underwent immunosuppressive treatment. Hyponatremia was also observed to improve gradually after the administration of prednisolone and cyclosporine concurrent with water restriction.
In humans, immune-mediated diseases such as systemic lupus erythematosus (SLE) can cause SIADH [13] . Autoimmune production of antiphospholipid antibodies (APL) has been recently reported as a cause of SIADH in SLE patients [8] . APL production is commonly observed in conjunction with autoimmune diseases and has been known to play a role in the regulation of synthesis, transport, and release of ADH [9] . SIADH associated with immune-mediated diseases has not been reported in animals. In this dog, suspected immune-mediated liver disease could be the cause of ADH release and SIADH. No other causes of SIADH were observed, and the response to the treatment with immunosuppressive medication also supports our diagnosis.
This case report describes SIADH occurring concurrently with liver disease in a dog. Immune-mediated liver disease has never been implicated as the cause of SIADH. However, this case study had some limitations. The histopathological findings could not be used to definitively diagnose liver disease, and a direct correlation between SIADH and the liver disease could not be established. However, on the basis of the clinical signs, the results of the several laboratory examinations and the patient's therapeutic response, a definitive diagnosis of SIADH with a concurrent liver disease was made.
